Application Note: Cardiotoxicity: Elevations of Cardiac Troponin-I Quantified with the Erenna cTnl Immunoassay
9 October 2012

In this application note, cTnl measured by the Erenna® Immunoassay System, from Singulex, was more sensitive than histopathology and other clinical platforms currently available to identify acute cardiotoxicity. The potential of the Erenna cTnl assay for improving the safety profiles of candidate drugs is also demonstrated.

Download PDF >>PDF Icon

Read the full article...

  Become a member
  • Quick and complete access to all application articles

  • Download 10,000+
    applications and methods

  • Make informed buying decisions

Already a member?

Log in for full access to the article

Remember me